| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in RYTM over the last quarter tilts toward selling: insiders offloaded a net 258,450 shares worth roughly $28.8M.
RYTM sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 239.3K | $1.45M | - | |
| CFO | 114.0K | $11.93M | - | |
| VP | 55.7K | $6.54M | - | |
| Other | 29.4K | - | - | |
| Other | 15.9K | $1.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Meeker David P | President and CEO | Sale+OE10b5-1 | 50,000 | $102.67 | $5,133,442.06 | -17.3% | - | - | |
| Aug 31, 2026 | Smith Hunter C | Chief Financial Officer | Sale+OE10b5-1 | 62,774 | $105.46 | $6,619,913.40 | -35.5% | - | - | |
| Aug 13, 2026 | Garfield Alastair | Chief Scientific Officer | Sell10b5-1 | 7,763 | $117.57 | $912,703.13 | -77.2% | - | - | |
| Aug 13, 2026 | Shulman Joseph | Chief Technical Officer | Sale+OE10b5-1 | 5,079 | $119.75 | $608,210.25 | -24.2% | - | - | |
| Aug 13, 2026 | Lee Jennifer Kayden | EVP, Head of North America | Sale+OE10b5-1 | 75,834 | $117.38 | $8,901,531.42 | - | - | - | |
| Aug 12, 2026 | Mazabraud Yann | EVP, Head of International | Sale+OE10b5-1 | 57,000 | $116.15 | $6,620,575.23 | -50.6% | - | - | |
| Jun 22, 2026 | Tetrault Lynn A. | Director | Sale+OE10b5-1 | 37,000 | $100.32 | $3,711,895.50 | -84.1% | -2.5% | - | |
| May 15, 2026 | German Christopher Paul | Corporate Controller &CAO | Sale+OE | 4,643 | $92.21 | $428,131.03 | - | +28.2% | - | |
| Mar 4, 2026 | German Christopher Paul | Corporate Controller &CAO | Sale+OE | 5,614 | $89.56 | $502,789.84 | -97.2% | -7.3% | - | |
| Feb 19, 2026 | Smith Hunter C | Chief Financial Officer | Sell10b5-1 | 7,954 | $101.31 | $805,813.76 | -6.7% | -12.1% | - |